Showing results (151-160 of 213) with videos related to
Sort By:
Pageof 22
JAMA Psychiatry|February 12, 2025
Making Progress in Clinical Trials for Suicide Prevention: A ReviewSamuel T Wilkinson, Craig J Bryan, Larry D Alphs, et al.Journal of Affective Disorders|July 19, 2024
A replication study using the World Health Organization pharmacovigilance database (VigiBase®) to evaluate whether an association between ketamine and esketamine and alcohol and substance misuse existsAngela T H Kwan, Joshua D Rosenblat, Rodrigo B Mansur, et al.Expert Opinion on Drug Safety|May 28, 2024
Association between dual orexin receptor antagonists (DORAs) and suicidality: reports to the United States Food and Drug Administration Adverse Event Reporting System (FAERS)Roger S McIntyre, Sabrina Wong, Angela T H Kwan, et al.Journal of Affective Disorders|April 18, 2024
Number needed to treat (NNT) for ketamine and esketamine in adults with treatment-resistant depression: A systematic review and meta-analysisCameron N Calder, Angela T H Kwan, Kayla M Teopiz, et al.Journal of Affective Disorders|December 15, 2022
Biomarkers of ketamine's antidepressant effect: An umbrella reviewShakila Meshkat, Roger C Ho, Bing Cao, et al.Journal of Affective Disorders|October 21, 2024
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and suicidality: A replication study using reports to the World Health Organization pharmacovigilance database (VigiBase®)Roger S McIntyre, Rodrigo B Mansur, Joshua D Rosenblat, et al.International Clinical Psychopharmacology|May 10, 2024
Risk of VMAT2 inhibitors on suicidality and parkinsonism: report utilizing the United States Food and Drug Administration adverse event reporting systemSabrina Wong, Gia Han Le, Angela T H Kwan, et al.Drug Metabolism Reviews|April 24, 2024
Effects of cannabidiol and Δ<sup>9</sup>-tetrahydrocannabinol on cytochrome P450 enzymes: a systematic reviewSarah Ann Smith, Gia Han Le, Kayla M Teopiz, et al.Journal of Addiction Medicine|August 14, 2023
Homelessness and Treatment Outcomes Among Black Adults With Opioid Use Disorder: A Secondary Analysis of X:BOTMarissa Justen, Jennifer Scodes, Martina Pavlicova, et al.Psychotherapy and Psychosomatics|January 25, 2024
Neuropsychological Assessments of Cognitive Impairment in Major Depressive Disorder: A Systematic Review and Meta-Analysis with Meta-RegressionTaeho Greg Rhee, Sung Ryul Shim, Kevin J Manning, et al.Pageof 22